First use of Philips’ breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter Only FDA-cleared solution for advanced IVC filter removal safely ablates tissue and removes embedded IVC filters in first patients In the USA, estimates show more than […]
Peripheral/Endo
MicroVention Announces First Patient Enrolled in the STRAIT Study with the New BOBBY™ Balloon Guide Catheter
ALISO VIEJO, Calif., April 20, 2022 /PRNewswire/ — MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a multi-center, prospective EU observational study called STRAIT, to evaluate the Safety and Performance of the BOBBY Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke. The BOBBY Balloon […]
PIVLAZ (clazosentan) – Idorsia’s first commercial product – now available for patients in Japan
In Japan, PIVLAZ™ (clazosentan) 150 mg, is indicated for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction and cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage (aSAH) securing. With the positive listing decision, Japan’s National Health Insurance system has recognized that the clinical efficacy demonstrated with PIVLAZ fulfills an important medical […]
Avinger Announces Full Commercial Launch of Lightbox 3
REDWOOD CITY, CA / ACCESSWIRE / April 19, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced full commercial availability of its new Lightbox 3 imaging console designed to enhance the […]
BENDIT Technologies Receives U.S. Food and Drug Administration 510(k) Clearance of its Bendit 021″ steerable microcatheter
TEL AVIV, Israel, April 18, 2022 /PRNewswire/ — BENDIT Technologies, a company focused on the development of a steerable microcatheter platform, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bendit21 microcatheter for treatment in the neuro, peripheral, and coronary vasculature. The clearance was received several […]
Penumbra Announces the European Launch of the Indigo® System With Lightning™ 7 and Lightning 12 Intelligent Aspiration
Physicians in Europe now have access to Penumbra’s most advanced mechanical thrombectomy technology available, which has had a significant impact on patients in the U.S. Designed for single session blood clot removal in peripheral arterial and venous systems, including the treatment of pulmonary embolisms First and only computer-aided mechanical aspiration […]
Koya Medical Launches Dayspring® Lower Extremity Active Compression Treatments for Lymphedema and Venous Disorders
Centers for Medicare & Medicaid Services (CMS) issues new Healthcare Common Procedure Coding System (HCPCS) codes for Dayspring lower extremity active compression OAKLAND, Calif.–(BUSINESS WIRE)–Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced the U.S. […]
FDA Clears Four New Coronary Micro Support Catheters
Non-tapered metal-alloy support catheter platform receives FDA clearance for use in coronary and peripheral vasculature. Transit Scientific now has one of the largest platforms of FDA cleared microcatheters in the industry. PARK CITY, Utah, April 12, 2022 /PRNewswire/ — Transit Scientific announced the FDA clearance of its XO Cross® Support Catheter Platform to […]
Alucent Biomedical Announces First Patient Enrolled in First In Human Natural Vascular Scaffolding Clinical Trial
Multicenter ACTIVATE II Study to Enroll up to 50 Patients in Australia SALT LAKE CITY–(BUSINESS WIRE)–Alucent Biomedical Inc. announced that it has enrolled the first patient in ACTIVATE II, an Australia-based First-in-Human clinical trial to evaluate the safety and efficacy of its revolutionary Natural Vascular Scaffolding (AlucentNVS) technology. The therapy is […]
TRUVIC Announces 510(k) Clearance for the Prodigy™ Thrombectomy System
First regulatory milestone as part of a strategy to advance patient care CAMPBELL, Calif.–(BUSINESS WIRE)–Truvic Medical, Inc., a wholly owned subsidiary of Imperative Care, Inc., today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Prodigy™ Thrombectomy System, designed for the treatment of peripheral […]



